Emergency Contraception in Italy
Euromonitor International's Emergency Contraception in Italy market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 44 | Publication date: Mar 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Table of contents
OTC HEALTHCARE IN ITALY : MARKET INSIGHT
EXECUTIVE SUMMARY
A positive result driven by price liberalisation
The weak effects of deregulation
A fragmented market led by Bayer
Chemists/pharmacies remain the undisputed leaders
Vitamins and dietary supplements will be growth driver
KEY TRENDS AND DEVELOPMENTS
A very old country
What price? The effects of price liberalisation
The results of the new Bersani law
Are parapharmacies/drugstores true competitors?
The need for a healthier lifestyle
Pharmaclick - a new distributor?
MARKET DATA
Table 1 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 2 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 3 OTC Healthcare Company Shares by Value 2004-2008
Table 4 OTC Healthcare Brand Shares by Value 2005-2008
Table 5 Penetration of Private Label by Sector 2003-2008
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-listing or De-reimbursement
Advertising
Packaging and Waste
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventive Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
Sources
Summary 2 Research Sources
LOCAL COMPANY PROFILES - ITALY
A MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
Summary 4 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2008
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 9 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2008
BAYER SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Bayer SpA: Key Facts
Summary 11 Bayer SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Bayer SpA: Competitive Position 2008
BRACCO SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Bracco SpA: Key Facts
Summary 14 Bracco SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Bracco SpA: Competitive Position 2008
CHIESI FARMACEUTICI SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Chiesi Farmaceutici SpA: Key Facts
Summary 17 Chiesi Farmaceutici SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 18 Chiesi Farmaceutici SpA: Competitive Position 2008
PERFETTI VAN MELLE SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 19 Perfetti Van Melle SpA: Key Facts
Summary 20 Perfetti Van Melle SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 21 Perfetti Van Melle SpA: Competitive Position 2008
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 22 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
Summary 23 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 24 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 25 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2008
SANOFI-AVENTIS SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 26 Sanofi-Aventis SpA: Key Facts
Summary 27 Sanofi-Aventis SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 28 Sanofi-Aventis SpA: Competitive Position 2008
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts
Summary 30 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 31 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2008
ZAMBON ITALIA SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 32 Zambon Italia SpA: Key Facts
Summary 33 Zambon Italia SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 34 Zambon Italia SpA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 35 Zambon Italia SpA: Competitive Position 2008
EMERGENCY CONTRACEPTION IN ITALY
HEADLINES